You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
Drugmaker
since
auto-detected in 8 stories
28 days ago
Drugmaker expands push into fast-growing market
4 months ago
Bristol-Myers buys Orbital Therapeutics for $1.5 billion ○
Drugmaker Bristol-Myers Squibb said on Friday it will acquire privately held cell therapy developer Orbital Therapeutics for $1.5 billion in cash.
5 months ago
Novo Nordisk tells staff to return to office full-time amid CEO's revival effort ○
Drugmaker Novo Nordisk said it had told staff to return to the office as its new CEO tries to accelerate decision-making and improve its commercial execution.
6 months ago
Drugmaker GSK lands £372m in Covid jab pact ○
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
How Novo Nordisk lost its lead in the weight loss race ○
Drugmaker struggled to adapt to very high demand and a market where celebrities are more influential than doctors
9 months ago
23andMe sold out of bankruptcy to Regeneron ○
Drugmaker’s takeover could raise privacy concerns among genetics start-up’s 15mn users
Bankrupt DNA testing firm 23andMe to be purchased for $256m ○
found
a story from The Guardian ⚠️ › International
Drugmaker Regeneron Pharmaceuticals’ capture of genetic testing firm in bankruptcy auction raises privacy concerns
The drugmaker Regeneron Pharmaceuticals has agreed to buy the genetic testing firm 23…
Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million ○
Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies said on Monday.
page 1 of 1